Please provide your email address to receive an email when new articles are posted on . “The prednisone dosage in treatment of moderate to severe (myasthenia gravis [MG]) is commonly gradually ...
Avacopan and prednisone taper were associated with similar and substantial improvements in the control of active disease in multiple organ systems in the phase 3 ADVOCATE trial. Patients with ...
Please provide your email address to receive an email when new articles are posted on . Baseline prednisone use is associated with an increased risk for poor outcomes among patients with systemic ...
In a single-center, single-arm, open-label pilot study, 30 adults (mean age, 73.7 years) with GCA received 162 mg of tocilizumab as a subcutaneous injection once a week for 52 weeks, plus prednisone ...
Credit: Getty Images. Avacopan plus rituximab offers a superior remission rate at 52 weeks and lower risk of relapse compared with prednisone taper plus rituximab, with a similar safety profile.
I’d become an eating machine with a loathsome attitude on prednisone, so I decided to conduct my own taper of the drug. Four months after my allogeneic bone marrow transplant, I left the Stanford ...
Tapering doses of prednisone were administered in a blinded fashion at an initial dose of 15 mg per day for 2 weeks in the two groups to ensure adequate disease control at baseline (Table S1 in the ...
Credit: Getty images. Study authors assessed whether the addition of a prednisone taper could decrease opioid use in patients undergoing tonsillectomy, tonsillectomy and adenoidectomy, or expansion ...
Gradual withdrawal of glucocorticoids was successful among patients with systemic lupus erythematosus (SLE) after 2 years of clinically quiescent disease, without an increased likelihood of flares, ...
Avacopan was safe and effective among patients with respiratory tract manifestations of antineutrophil cytoplasmic antibody-associated vasculitis. Avacopan shows promising efficacy and safety among ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results